Treatment Information

Back

Mesothelioma treatment details. Chemotherapy, Biologic therapy.

The Royal Marsden Hospital, Sutton, United Kingdom.

Survival: monthsCountry:United Kingdom
Toxiciy Grade:3City/State/Province:Sutton
Treatments:Chemotherapy, Biologic therapyHospital:The Royal Marsden Hospital
Drugs:Journal:Link
Date:Feb 2002

Description:

Patients: This Phase I study involved 13 patients with malignant mesothelioma.

Treatment: The treatment consisted of a suspension of heat-killed Mycobacterium vaccae (SRL172), a fast growing avirulent mycobacterium, that may have non-specific immunomodulating properties in combination with standard chemotherapy (mitomycin-C (mitozytrex), vinblastine (velban) and cisplatin (platinol)).

Toxicity: Grade 1-3 toxicities included infection, emesis, mucositis, diarrhea, constipation, alopecia, neuropathy, fatigue, and hematological.

Results: The median overall survival was 10.5 months.

Support: This study was supported by a research grant from SR Pharma. SR Pharma markets SRL172.

Correspondence: MER O’Brien, MD





Back